Delivery Order SPE2DR25D6028-SPE2DR26FATEM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,019.18 to AmerisourceBergen Drug Corp for 20,000 units of Recothrom on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 13, 2025, for 20,000 unit vials of Recothrom at a ceiling value of $15,525.34. This firm fixed price, non-set-aside contract is set for completion by November 14, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This delivery order, valued at $4,087.14, was awarded on September 24, 2025, to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom. The contract was funded by the Defense Logistics Agency (DLA), a Department of Defense organization responsible for supplying medical and other commodities to military and federal healthcare systems. The award utilized firm fixed-price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a $1,789.73 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, issued on December 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.32 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- This delivery order, awarded May 12, 2025, obligates $8,481.60 to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. The award is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. Performance will be completed by May 13, 2025, at the...
- The Defense Logistics Agency (DLA) awarded a $1,335.30 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 20,000 units of the pharmaceutical product RECOTHROM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has...
- The Defense Logistics Agency awarded a delivery order valued at approximately $81,912 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price, non-set-aside contract was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,513.82 fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a specialty medication. The contract has a period of performance through December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a $4,612.79 delivery order to AmerisourceBergen Drug Corp for 20,000 units of Recothrom spray kits, with a completion date of December 4, 2025. This competitive award, issued on December 3, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters operations. This delivery order is a...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATEMDelivery Order
This delivery order, valued at $2,463.48, was awarded to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Recothrom pharmaceutical product totaling 20,000 units. The contract is a firm fixed price delivery order with a completion date of December 31, 2025, issued by the Defense Logistics Agency (DLA) through its Medical Supply Chain operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement without set-aside restrictions, reflecting the company's demonstrated capability to fulfill federal medical supply requirements. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems, AmerisourceBergen has established itself as a critical vendor within the DLA's Medical Supply Chain, providing everything from specialty medications and vaccines to medical devices and diagnostic supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/29/25 |